Lobe Sciences Statistics
Want to see TSE:LOBE full AI Analyst Report?
Lobe Sciences (LOBE) Stock Statistics & Valuation Metrics
Total Valuation
Lobe Sciences has a market cap or net worth of CAD 13.87M. The enterprise value is CAD 25.61M.
- Market Cap
- CAD 13.87M
- Enterprise Value
- CAD 25.61M
Share Statistics
Lobe Sciences has 308,182,160 shares outstanding. The number of shares has decreased by -2.65% in one year.
- Shares Outstanding
- 308,182,160
- Owned by Insiders
- 97.06%
- Owned by Institutions
- ―
Financial Efficiency
Lobe Sciences’s return on equity (ROE) is -1.88 and return on invested capital (ROIC) is -80.88%.
- Return on Equity (ROE)
- -1.88
- Return on Assets (ROA)
- -0.58
- Return on Invested Capital (ROIC)
- -80.88%
- Return on Capital Employed (ROCE)
- -0.81
- Revenue Per Employee
- 0
- Profits Per Employee
- -885.53K
- Employee Count
- 5
- Asset Turnover
- 0.00
- Inventory Turnover
- 0.00
Valuation Ratios
The current PE Ratio of Lobe Sciences is -2.18. Lobe Sciences’s PEG ratio is -0.05.
- PE Ratio
- -2.18
- PS Ratio
- 0.00
- PB Ratio
- 6.63
- Price to FCF
- -3.29
- Price to Operating Cash Flow
- -3.34
- PEG Ratio
- -0.05
Income Statement
In the last 12 months, Lobe Sciences had revenue of 0 and earned -4.43M in profits. Earnings per share was -0.03.
- Revenue
- 0
- Gross Profit
- 0
- Operating Income
- -4.18M
- Pretax Income
- -4.86M
- Net Income
- -4.43M
- EBITDA
- -4.27M
- Earnings Per Share (EPS)
- -0.03
Cash Flow
In the last 12 months, operating cash flow was -3.74M and capital expenditures -8, giving a free cash flow of -3.74M billion.
- Operating Cash Flow
- -3.74M
- Free Cash Flow
- -3.74M
- Free Cash Flow per Share
- -0.01
Dividends & Yields
Lobe Sciences pays an annual dividend of ―, resulting in a dividend yield of ―
- Dividend Per Share
- ―
- Dividend Yield
- ―
- Payout Ratio
- N/A
- Free Cash Flow Yield
- -30.37%
- Earnings Yield
- -41.35%
Stock Price Statistics
- Beta
- 0.67
- 52-Week Price Change
- 12.50%
- 50-Day Moving Average
- 0.06
- 200-Day Moving Average
- 0.08
- Relative Strength Index (RSI)
- 47.77
- Average Volume (3m)
- 126.62K
Important Dates
Lobe Sciences upcoming earnings date is Dec 18, 2026, TBA (Not Confirmed).
- Last Earnings Date
- Jul 30, 2026
- Next Earnings Date
- Dec 18, 2026
- Ex-Dividend Date
- ―
Financial Position
Lobe Sciences as a current ratio of 3.13, with Debt / Equity ratio of 11.60%
- Current Ratio
- 3.13
- Quick Ratio
- 3.13
- Debt to Market Cap
- 0.04
- Net Debt to EBITDA
- 1.31
- Interest Coverage Ratio
- -7.00
Taxes
In the past 12 months, Lobe Sciences has paid 0 in taxes.
- Income Tax
- 0
- Effective Tax Rate
- 0.00
Enterprise Valuation
Lobe Sciences EV to EBITDA ratio is -1.62, with an EV/FCF ratio of -2.98.
- EV to Sales
- 0.00
- EV to EBITDA
- -1.62
- EV to Free Cash Flow
- -2.98
- EV to Operating Cash Flow
- -2.98
Balance Sheet
Lobe Sciences has CAD 5.21M in cash and marketable securities with CAD 338.40K in debt, giving a net cash position of CAD 4.87M billion.
- Cash & Marketable Securities
- CAD 5.21M
- Total Debt
- CAD 338.40K
- Net Cash
- CAD 4.87M
- Net Cash Per Share
- CAD 0.02
- Tangible Book Value Per Share
- CAD 0.01
Margins
Gross margin is 0.00%, with operating margin of 0.00%, and net profit margin of 0.00%.
- Gross Margin
- 0.00%
- Operating Margin
- 0.00%
- Pretax Margin
- 0.00%
- Net Profit Margin
- 0.00%
- EBITDA Margin
- 0.00%
- EBIT Margin
- 0.00%
Analyst Forecast
The average price target for Lobe Sciences is ―, which is 11.43% higher than the current price. The consensus rating is ―
- Price Target
- ―
- Price Target Upside
- ―
- Analyst Consensus
- ―
- Analyst Count
- ―
- Revenue Growth Forecast
- ―
- EPS Growth Forecast
- 31.00%
Scores
- Smart Score
- ―
- AI Score
- 43
